Skip to main content

Sonoma Pharmaceuticals, Inc.

corporate_fare Company Profile

Sonoma Pharmaceuticals, Inc.

SNOA·NASDAQ·Industrial Applications And Services·CIK 0001367083

Sonoma Pharmaceuticals, Inc. is a global healthcare company that develops and produces stabilized hypochlorous acid (HOCl) products. These products are used in various applications such as wound care, eye care, dermatological conditions, podiatry, animal health care, and as non-toxic disinfectants. The company's products are clinically proven to safely reduce itch, pain, scarring, and irritation without damaging healthy tissue. In-vitro and clinical studies demonstrate that HOCl can safely manage skin abrasions, lacerations, minor irritations, cuts, and intact skin. Sonoma Pharmaceuticals sells its products directly or through partners in over 55 countries worldwide. The company has two active wholly-owned subsidiaries: Oculus Technologies of Mexico, S.A. de C.V., and Sonoma Pharmaceuticals Netherlands, B.V. Its principal executive offices are located in Boulder, Colorado. The company's fiscal year ends on March 31. In March 2026, Sonoma Pharmaceuticals launched its advanced HOCl-based burn relief hydrogel in CVS and Walmart stores across the United States.

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for SNOA at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Sonoma Pharmaceuticals Appoints Biotech Finance Veteran Vanessa Jacoby to Board, Audit Chair
  • Sonoma Pharmaceuticals Files Investor Presentation Highlighting Strong Growth, New Products, and Expanded Distribution

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$19.53M
Net Income
-$3.17M
Diluted EPS
-$1.89
Op. Cash Flow
-$3.93M
Free Cash Flow
-$4.13M
Gross Profit
$7.42M
Operating Income
-$2.46M
Cash & Equivalents
$2.4M
Total Debt
$222K
Debt / Equity
0.07×
Net Margin
-16.3%
Shares Outstanding
1.8M sh
Source: 10-K · filed 2026-06-16 · accession 0001683168-26-004871
$0.81 -2.17% today
52-week range · as of 2026-11-13 $0.81 – $3.95
Market cap
$3.65M
Volume
103.7K (1.4× avg)
3-mo avg 73.4K
Live data · 2026-11-22 12:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SNOA - Filings & News (Page 2)

SNOA
Jan 28, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.39
Real-time Price: $0.810 info
Change: -$2.58 (-76%) info
Market Cap: $3.654M info
SNOA
Jan 12, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.78
Real-time Price: $0.810 info
Change: -$2.97 (-79%) info
Market Cap: $3.654M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets